Skip to main content
Equibles

HRT FINANCIAL LP

Position in AKTX — Akari Therapeutics Plc

CIK 1475597 NEW YORK, NY
Back to AKTX Full portfolio

Position in AKTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$140,817
+$108,920 QoQ
Shares Held
13,745
+57170.8% QoQ
Ownership
0.706%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 9 holders
Holding Since
Jun 2020
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $857,639,414 across 185 Biotechnology names. AKTX ranks #108 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 1,089,376 $81,136,724
2 INSM
INSMED Inc
 689,981 $73,565,774
3 EXEL
Exelixis, Inc.
 929,242 $50,560,057
4 MDGL
Madrigal Pharmaceuticals, Inc.
 84,634 $45,444,226
5 AXSM
Axsome Therapeutics, Inc.
 178,491 $43,689,242
6 ARWR
Arrowhead Pharmaceuticals, Inc.
 498,655 $40,645,369
7 ABVX
Abivax S.A.
 270,612 $36,061,755
8 TGTX
Tg Therapeutics, Inc.
 622,603 $34,205,808

All Filings in AKTX

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $140,817 13,745
2021-09-30 $31,897 19,569
2021-06-30 $37,722 21,805
2021-03-31 $42,469 16,087
2020-09-30 $88,305 50,750
2020-06-30 $26,800 12,294